CHLOE MILLER: Open Payments
NPI 1609492495 · ANDERSON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$309 in 13 payments from 10 companies in 2025. Trend: 2023 $388 · 2024 $96 · 2025 $309
Food & beverage: $309
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 2 | $76 |
| Insulet Corporation | 2 | $50 |
| SANOFI-AVENTIS U.S. LLC | 2 | $42 |
| Medtronic, Inc. | 1 | $29 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| BETA BIONICS, INC. | 1 | $21 |
| Mannkind Corporation | 1 | $20 |
| Amgen Inc. | 1 | $19 |
| Novo Nordisk Inc | 1 | $14 |
| Antares Pharma, Inc. | 1 | $14 |
Products named: REZDIFFRA, Omnipod, TZIELD, MINIMED 780G, GVOKE HYPOPEN, iLet Bionic Pancreas, AFREZZA, REPATHA.
Industry payments across IN — which companies pay providers there.
